Results 121 to 130 of about 42,543 (244)
Cancer therapeutic trispecific antibodies recruiting both T and natural killer cells to cancer cells. [PDF]
Kimura K +5 more
europepmc +1 more source
Mechanisms and clinical advancements of cell-based immunotherapies in non-small cell lung cancer: an integrated perspective. [PDF]
Yang L, Gong Y.
europepmc +1 more source
Perspectives of adaptive immunotherapy using lymphokine activated killer (LAK) cells.
Michio Imawari
openalex +2 more sources
Design of a prodrug bispecific antibody masked by a functional molecule for lymphocyte activation for cancer therapy. [PDF]
Miura D +4 more
europepmc +1 more source
Characterization of cytotoxic cells from reovirus-infected SCID mice: activated cells express natural killer- and lymphokine-activated killer-like activity but fail to clear infection [PDF]
J Taterka, John J. Cebra, D H Rubin
openalex +1 more source

